Drugs / B-subunit of non-toxic cholera toxin
B-subunit of non-toxic cholera toxin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00820144 | Apr 2006 | infectious disease | Centre Hospitalier Universitaire de Nice | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | B-subunit of non-toxic cholera toxin | “exploring and comparing the mucosal immune response after oral, nasal and sublingual administration of B-subunit of non-toxic cholera toxin (CTB) in healthy adult volunteers.” NCT00820144 ↗ |
| Known as | Cholera Toxin B subunit | “It is based on the mucosal administration (oral, nasal, rectal, vaginal) comprising a combination of antigen bound (either chemically or by genetic fusion) to the non-toxic...” NCT00820144 ↗ |
| Known as | CTB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00820144 ↗ |
| Modality | Protein / enzyme biologic | “B-subunit of non-toxic cholera toxin (CTB)” NCT00820144 ↗ |
| Route | Intranasal | “CTB by nasal way” NCT00820144 ↗ |